Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Levy

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Blood|June 28, 2019
Prevalence of <i>BTK</i> and <i>PLCG2</i> mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group studyAnne Quinquenel, Luc-Matthieu Fornecker, Rémi Letestu, et al.
British Journal of Haematology|November 19, 2016
Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patientsAnne Wanquet, Rudy Birsen, Charlotte Bonnet, et al.
Infectious Diseases (London, England)|May 24, 2021
A short course of corticosteroids reduces the risk of mechanical ventilation and death in patients with moderate to severe COVID 19 pneumonia: results of a retrospective monocentric cohortCeline Comparon, Marouane Boubaya, Nanthara Sritharan, et al.
JHEP Reports : Innovation in Hepatology|January 1, 2025
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 studyJean-Charles Nault, Nanthara Sritharan, Gontran Verset, et al.
American Journal of Hematology|August 17, 2016
Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 casesSara Melboucy-Belkhir, Mehdi Khellaf, Alexandre Augier, et al.
Leukemia|February 20, 2020
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trialCarmen D Herling, Florence Cymbalista, Carolin Groß-Ophoff-Müller, et al.
Blood Cancer Journal|May 29, 2020
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-upJerome Paillassa, Edouard Cornet, Stephanie Noel, et al.
Blood|November 9, 2020
A fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trialAnne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, et al.
The Lancet. Gastroenterology & Hepatology|February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre studyJean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Blood|June 28, 2019
Prevalence of <i>BTK</i> and <i>PLCG2</i> mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group studyAnne Quinquenel, Luc-Matthieu Fornecker, Rémi Letestu, et al.
British Journal of Haematology|November 19, 2016
Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patientsAnne Wanquet, Rudy Birsen, Charlotte Bonnet, et al.
Infectious Diseases (London, England)|May 24, 2021
A short course of corticosteroids reduces the risk of mechanical ventilation and death in patients with moderate to severe COVID 19 pneumonia: results of a retrospective monocentric cohortCeline Comparon, Marouane Boubaya, Nanthara Sritharan, et al.
JHEP Reports : Innovation in Hepatology|January 1, 2025
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 studyJean-Charles Nault, Nanthara Sritharan, Gontran Verset, et al.
American Journal of Hematology|August 17, 2016
Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 casesSara Melboucy-Belkhir, Mehdi Khellaf, Alexandre Augier, et al.
Leukemia|February 20, 2020
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trialCarmen D Herling, Florence Cymbalista, Carolin Groß-Ophoff-Müller, et al.
Blood Cancer Journal|May 29, 2020
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-upJerome Paillassa, Edouard Cornet, Stephanie Noel, et al.
Blood|November 9, 2020
A fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trialAnne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, et al.
The Lancet. Gastroenterology & Hepatology|February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre studyJean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
Pageof 6